Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -51515.17% is 18% above its 5-year average of -63114.95%, near the high end of its 5-year range (-238316.84%–1256.60%).
As of the fiscal period ended Tuesday, March 31, 2026. 65.70% above its 12-month average of -150206.75%.
Reported quarterly operating margin; no daily interpolation. Q4 FY2026 (2026-03-31): -51515.17%.
OPERATING MARGIN
-51515.17%
OPERATING MARGIN AVG TTM
-150206.75%
OPERATING MARGIN AVG 3Y
-95751.77%
OPERATING MARGIN AVG 5Y
-63114.95%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+65.70%
CURRENT VS 3Y AVG
+46.20%
CURRENT VS 5Y AVG
+18.38%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Virax Biolabs Group Limited
Market Cap
$378849.00
Operating Margin
-51515.17%
TTM Avg
-150206.75%
3Y Avg
-95751.77%
5Y Avg
-63114.95%
Market Cap
$403887.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-952.12%
5Y Avg
-1206.12%
Market Cap
$481786.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$250443.00
Operating Margin
-1022.08%
TTM Avg
-791.13%
3Y Avg
-582.66%
5Y Avg
-578.16%
Market Cap
$518606.00
Operating Margin
-8567.94%
TTM Avg
-8664.53%
3Y Avg
-8990.40%
5Y Avg
-6121.14%
Market Cap
$545796.00
Operating Margin
-20757.65%
TTM Avg
-10953.08%
3Y Avg
-5758.86%
5Y Avg
-3862.92%
Market Cap
$110112.00
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$95475.00
Operating Margin
N/A
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$667469.00
Operating Margin
N/A
TTM Avg
-409.01%
3Y Avg
-308.21%
5Y Avg
-246.38%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Virax Biolabs Group Limited (VRAX) | $378849.00 | -51515.17% | -150206.75% | -95751.77% | -63114.95% |
| Niki BioSolutions, Inc. (NIKI)vs › | $403887.00 | 0.00% | 0.00% | -952.12% | -1206.12% |
| XORTX Therapeutics Inc. (XRTX)vs › | $481786.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| SciSparc Ltd. (SPRC)vs › | $250443.00 | -1022.08% | -791.13% | -582.66% | -578.16% |
| VivoSim Labs, Inc. (VIVS)vs › | $518606.00 | -8567.94% | -8664.53% | -8990.40% | -6121.14% |
| HCW Biologics Inc. (HCWB)vs › | $545796.00 | -20757.65% | -10953.08% | -5758.86% | -3862.92% |
| Silexion Therapeutics Ltd. (SLXN)vs › | $110112.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Psyence Biomedical Ltd. (PBM)vs › | $95475.00 | N/A | 0.00% | 0.00% | 0.00% |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $667469.00 | N/A | -409.01% | -308.21% | -246.38% |
| PRF Technologies Ltd. (PRFX)vs › | $70884.00 | -29335.29% | -14667.65% | -9912.02% | -6608.01% |
Gross Margin
61.9%
Operating Margin
-51515.2%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-03-31 | -51515.17% |
| 2025-09-30 | -160788.25% |
| 2025-03-31 | -238316.84% |
| 2024-09-30 | -58124.19% |
| 2024-03-31 | -4742.61% |
| 2023-09-30 | -3537.54% |
| 2023-03-31 | -153237.77% |
| 2022-09-30 | -25010.07% |
| 2022-03-31 | 1256.60% |
| 2021-09-30 | 0.00% |
| 2021-03-31 | -248.66% |
| 2020-09-30 | -2653.29% |
| 2020-03-31 | -652.05% |
| 2019-09-30 | -652.05% |
